SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
追寻的觅柔
Lv1
50 积分
2022-09-29 加入
最近求助
最近应助
互助留言
Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure
7天前
已完结
Real-world study of PD-1/L1 immune checkpoint inhibitors for advanced non-small cell lung cancer after resistance to EGFR-TKIs
7天前
已完结
Identification of novel ALK fusions using DNA/RNA sequencing in immunohistochemistry / RT-PCR discordant NSCLC patients
13天前
已完结
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
1个月前
已完结
The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer
1个月前
已完结
Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy
1个月前
已关闭
Detecting anaplastic lymphoma kinase (ALK) gene rearrangements with next-generation sequencing remains a reliable approach in patients with non-small-cell lung cancer
1个月前
已完结
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
8个月前
已完结
Expression and potential role of CCL4 in CD8+T cells in NSCLC
8个月前
已完结
Single‐cell transcriptomic analysis reveals circadian rhythm disruption associated with poor prognosis and drug‐resistance in lung adenocarcinoma
8个月前
已完结
没有进行任何应助
点赞,感谢,速度真快,帮大忙了,么么哒
7天前
帮大忙了,么么哒,速度真快,点赞,感谢
13天前
感谢,点赞,速度真快,帮大忙了,么么哒
1个月前
已找到【积分已退回】
1个月前
感谢
8个月前
感谢,点赞
8个月前
感谢
8个月前
感谢
8个月前
感谢
9个月前
感谢,点赞,速度真快,帮大忙了,么么哒
9个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论